Azuraophthalmics
Founded 2014 · 11 employees on LinkedIn · 1 known investors
Azura Ophthalmics develops first-in-class keratolytic-based therapies for lid margin and ocular surface diseases, combining ophthalmologic and dermatologic approaches to treat underserved ocular indications. The company operates in the clinical-stage biopharmaceutical space focused on ophthalmology.
Investors · 1
Frequently asked questions
- What does Azuraophthalmics do?
- Azura Ophthalmics develops first-in-class keratolytic-based therapies for lid margin and ocular surface diseases, combining ophthalmologic and dermatologic approaches to treat underserved ocular indications. The company operates in the clinical-stage biopharmaceutical space focused on ophthalmology.
- Who are Azuraophthalmics's investors?
- Azuraophthalmics's investors include OrbiMed.